Skip to main content

Table 1 Propensity score matched data

From: Combined use of topical intraarticular tranexamic acid and rivaroxaban in total knee arthroplasty safely reduces blood loss, transfusion rates, and wound complications without increasing the risk of thrombosis

 

Rivaroxaban only

(n = 52)

Rivaroxaban + IA TXA

(n = 52)

p-value

Age (years)a

70.4 (68.0–72.9)

72.0 (70.0–74.0)

0.320

Male:Femaleb

6: 46

8: 44

0.775

BMI (kg/m2)a

25.1 (24.2–26.1)

25.0 (24.4–25.7)

0.816

ASA-PS classificationa

2.1 (1.9–2.2)

2.1 (2.0–2.3)

0.704

Preoperative Hb (g/dL)a

12.5 (12.1–12.9)

12.6 (12.2–13.0)

0.630

  1. IA TXA Intraarticular tranexamic acid, BMI Body mass index, ASA-PS American Society of Anesthesiologists Physical Status, Hb Haemoglobin
  2. aValues presented as means (95% confidence interval) and compared by independent t-tests
  3. bValues presented as proportions and compared using Pearson’s chi-square test
Back to article page

BMC Musculoskeletal Disorders

ISSN: 1471-2474

Contact us